Ken Griffin
PCVX icon

Ken Griffin’s Vaxcyte PCVX Stock Holding History

Ken Griffin’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.97M Buy
102,800
+57,900
+129% +$3.14M ﹤0.01% 4046
2025
Q4 		$2.07M Buy
44,900
+28,400
+172% +$1.27M ﹤0.01% 5841
2025
Q3 		$594K Sell
16,500
-15,100
-48% -$500K ﹤0.01% 8703
2025
Q2 		$1.03M Buy
31,600
+13,400
+74% +$439K ﹤0.01% 7026
2025
Q1 		$687K Sell
18,200
-8,300
-31% -$664K ﹤0.01% 7784
2024
Q4 		$2.17M Sell
26,500
-20,200
-43% -$2.01M ﹤0.01% 5458
2024
Q3 		$5.34M Buy
46,700
+15,200
+48% +$1.37M ﹤0.01% 3835
2024
Q2 		$2.38M Sell
31,500
-3,200
-9% -$218K ﹤0.01% 4998
2024
Q1 		$2.37M Buy
34,700
+32,500
+1,477% +$2.25M ﹤0.01% 5193
2023
Q4 		$138K Hold
2,200
– – ﹤0.01% 10514
2023
Q3 		$112K Sell
2,200
-15,000
-87% -$740K ﹤0.01% 10747
2023
Q2 		$859K Buy
17,200
+14,200
+473% +$673K ﹤0.01% 6773
2023
Q1 		$112K Buy
3,000
+2,100
+233% +$89.1K ﹤0.01% 11086
2022
Q4 		$43.2K Sell
900
-528,300
-100% -$20.7M ﹤0.01% 12313
2022
Q3 		$12.7M Buy
+529,200
New +$13.4M ﹤0.01% 2421

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ken Griffin's PCVX Position: Q1 2026 in Review

Ken Griffin sold out of Vaxcyte (PCVX) in Q1 2026, closing a stake of 326,574 shares — an estimated $17.7M sold.

Ken Griffin first reported a position in PCVX in Q2 2020 and held it in 20 quarters. The position peaked at $40.8M in Q4 2022. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Ken Griffin reported no remaining Vaxcyte position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 326,574 Vaxcyte shares in Q1 2026, an estimated $17.7M.
  • Ken Griffin first reported a position in Vaxcyte in Q2 2020 and held it in 20 quarters.
  • Ken Griffin's Vaxcyte position peaked at $40.8M in Q4 2022.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.